From June 9 – 11, FCF is hosting its sixth Fibrolamellar Scientific Summit. The goal of this meeting is to bring together the fibrolamellar research community to share research knowledge and to collaborate in the search for a cure.
To encourage the sharing of unpublished information, the scientific discussions in the main session will be open only to researchers who have signed a multi-party non-disclosure agreement. However, the event’s introductory keynote discussion (June 9, 2025 from 8 – 9 pm ET) will be open for virtual participation by the entire fibrolamellar community – patients, caregivers, clinicians and researchers.
This year’s keynote will be a panel discussion exploring the great progress being made in targeted immunotherapy against FLC. It will feature:
- Mark Furth, PhD, Chief Science Officer, FCF (moderator)
- Juliane Walz, MD, University of Tübingen
- Mark Yarchoan, MD, Johns Hopkins University
- Molly Hones, FLC patient and clinical trial participant.
Please click here to register for the event.